MENU
HRTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Heron Therapeutics (HRTX) Ownership - Who owns Heron Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
4242 Campus Point Court
Phone
+1 858 251-4400
Employees
126
Web
https://www.herontx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
250.96M
P/E Ratio
N/A
Total Cash
56.93M
Projected Growth
N/A
Total Debt
179.17M
Revenue
N/A
Risk (Beta)
2.02
Dividend Yield
N/A
Total Cash/Share
0.37
Total Debt/Equity
N/A
Revenue/Share
0.91 USD as % of share price
Fundamentals
HRTX
Capitalization
251M
P/E Ratio
N/A
Risk (Beta)
2.02
Dividend Yield
N/A
Total Cash
56.9M
Total Cash/Share
0.37
Total Debt
179M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.91%
Revenue
N/A
ROE
N/A
Book Value
-33.77M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.5M
Current Ratio
2.47
Current Revenue Per Employee
275158.72
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
75.64
Revenue To Assets
N/A
Shares Held By Institutions
506M
Shares Outstanding - Current
152M
Total Liabilities
252M
Total Volume MTD
N/A
Value
-1
Gain YTD
-2.941
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of polymer technologies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
4242 Campus Point Court
Phone
+1 858 251-4400
Employees
126
Web
https://www.herontx.com